User:SDZeroBot/NPP sorting/STEM/Chemistry
| Tutorial | Discussion | New page feed | Reviewers | Curation tool Suggestions | Coordination |
 | 11 unreviewed articles as of 1 August 2025
|
| Created | Article | Extract | Class | Creator (# edits) | Notes |
|---|---|---|---|---|---|
| 2024-11-10 | Qing-Yun Chen (Chinese chemist (1929-2023)) | Qing-Yun Chen (Chinese: 陈庆云; pinyin: Chén Qìngyún; 25 January 1929 – 2 March 2023) was a Chinese organic chemist and member of the Chinese Academy of Sciences, specializing in the field of organic fluorine chemistry. | Start | Tokisaki Kurumi (8219) | |
| 2024-12-17 | Dazadrol (Dazadrol is an antidepressant) | Dazadrol is a synthetic antidepressant developed by Schering Corp in the late 1960s. It acts primarily as a noradrenaline reuptake inhibitor, increasing concentrations of noradrenaline in the synaptic cleft, which is believed to underlie its antidepressant effects. | Stub | Mo18ekula (260) | |
| 2024-12-15 | Potassium aspartate (Chemical compound) | Potassium aspartate is a potassium salt of L-aspartic acid, an amino acid, with the chemical formula KO2CCH(NH2)CH2CO2H·H2O. | C | Maxim Masiutin (31269) | |
| 2025-05-19 | Transition metal catalytic asymmetric dearomatization reactions (Category of organic chemical reactions) | Catalyzed asymmetric dearomatization reactions (CADA reactions) are a category of asymmetric dearomatization reactions that catalytically transform aromatic compounds into enantioenriched polycycles and heterocyclic skeletons. The term was coined in 2012 by You et al. | FA | PchemExtraordinaire (38) | |
| 2025-05-23 | Cefepime/sulbactam (Combination antibiotic consisting of the IV generation) | Cefepime/sulbactam is a 1:1 fixed-dose combination of cefepime (a fourth-generation cephalosporin) and sulbactam (a β-lactamase inhibitor). The combination exerts a bactericidal effect by disrupting bacterial cell wall synthesis through transpeptidase inhibition, thereby impairing peptidoglycan cross-linking. | C | Хокус Покус 333 (37) | |
| 2025-05-31 | Musahaqah | Musaheqeh (Arabic: مساحقه) is a legal and religious term. In Islamic jurisprudence (fiqh) and under the Islamic Penal Code of Iran, musaheqeh refers to a situation in which an adult, mentally competent, and consenting woman brings her genitalia into contact with the genitalia of another woman. | Stub | JesusisGreat7 (2215) | |
| 2025-07-17 | 177 Lu-NNS309 (Investigational radiopharmaceutical compound) | 177Lu-NNS309 is an investigational radiopharmaceutical compound currently under development by Novartis Pharmaceuticals for the treatment of various solid tumors. The compound is being evaluated in Phase I clinical trials for patients with pancreatic, lung, breast, and colorectal cancers. | C | Noxoug1 (5566) | |
| 2025-07-29 | Abolens (Village and district in Hannut, Liège Province, Belgium) | Abolens (Walloon: Å Bôlin) is a village and a district of the municipality of Hannut, located in the province of Liège, Belgium. The village is situated near the source of the river Jeker, which rises within its territory, as well as the Grande Bek. | Start | Bocanegra (35871) | |
| 2025-07-16 | IHCH-8134 (Chemical compound) | IHCH-8134 is a drug of the oxazinopyridoindole family which acts as an agonist at the 5-HT2A serotonin receptor. It was derived by structural simplification of the 5-HT2A antagonist atypical antipsychotic drug lumateperone along with several related compounds such as IHCH-7079, which was found to be a non-hallucinogenic biased 5-HT2A agonist that was active in antidepressant assays but did not produce psychedelic-like responding in mice. | Stub | BaeyerDrewson (646) | |
| 2025-05-22 | 225Ac-PSMA-R2 (Investigational radiopharmaceutical) | 225Ac-PSMA-R2 is an investigational radiopharmaceutical developed by Novartis for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC). It is a targeted alpha therapy (TAT) combining actinium-225 (225Ac), an alpha-emitting radionuclide, with PSMA-R2, a small-molecule ligand targeting prostate-specific membrane antigen (PSMA), a protein overexpressed in prostate cancer cells. | C | Noxoug1 (5566) | |
| 2025-07-29 | OpRegen (Allogeneic cell therapy) | OpRegen (also known as RG6501) is an investigational allogeneic cell therapy developed by Lineage Cell Therapeutics for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The therapy consists of human retinal pigment epithelial (RPE) cells administered via subretinal injection as a single treatment. | C | Noxoug1 (5566) |
Last updated by SDZeroBot operator / talk at 01:45, 1 August 2025 (UTC)